Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. RXL: which is better?

Bottom line

XLV vs RXL: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and RXL (ProShares Ultra Health Care) share a meaningful slice of their top holdings — about 78% by weight.

XLV is cheaper at 0.08% vs 0.95% — a difference of $87 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +7.2% for RXL.

Updated Nov 19, 2026

XLV vs RXL side by side

XLVRXL
TypeETFETF
Fund familySPDR (State Street)ProShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.95%
Annual cost per $10k$8$95
10-yr cost on $10k (prospectus)$103$1,305
Max front loadNoneNone
12b-1 fee0.02%—
1-yr return+14.5%+19.7%
5-yr return (annualized)+8.1%+7.2%
10-yr return (annualized)+9.8%+12.6%
Best quarter+14.5%+29.7%
Worst quarter−12.7%−28.9%
Net assets (fund)$40.6B$72.1M
Number of holdings6570
Portfolio turnover2%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVRXLDifference
2025+14.5%+19.7%−5.2%
2024+2.5%−2.7%+5.2%
2023+2.0%−3.2%+5.2%
2022−2.1%−15.1%+13.1%
2021+25.9%+47.8%−21.9%
2020+13.3%+19.2%−6.0%
2019+20.7%+38.9%−18.3%
2018+6.3%+5.4%+0.9%
2017+21.7%+46.0%−24.3%
2016−2.8%−8.9%+6.1%

Source: Fund prospectus bar charts

Holdings overlap

21 of XLV's top 25 holdings also appear in RXL's top 25.

Shared top holdings
HoldingXLVRXL
Eli Lilly & Co16.51%12.67%
Johnson & Johnson10.64%7.86%
AbbVie Inc7.74%5.57%
UnitedHealth Group Inc6.57%4.98%
Merck & Co Inc5.52%4.26%
Amgen Inc3.40%2.62%
Thermo Fisher Scientific Inc3.24%2.68%
Abbott Laboratories2.75%2.15%
Gilead Sciences Inc2.73%2.41%
Intuitive Surgical Inc2.45%2.18%
Pfizer Inc2.39%2.15%
CVS Health Corp2.30%1.67%
Vertex Pharmaceuticals Inc2.19%1.64%
Danaher Corp2.09%1.66%
Bristol-Myers Squibb Co2.05%1.68%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

RXL top 10

  1. Eli Lilly & Co. — 12.67%
  2. ProShares GENIUS Money Market ETF — 11.81%
  3. Johnson & Johnson — 7.86%
  4. AbbVie, Inc. — 5.57%
  5. UnitedHealth Group, Inc. — 4.98%
  6. Merck & Co., Inc. — 4.26%
  7. Repurchase Agreement — 2.91%
  8. Thermo Fisher Scientific, Inc. — 2.68%
  9. Amgen, Inc. — 2.62%
  10. Gilead Sciences, Inc. — 2.41%

FAQ

What is the difference between XLV and RXL?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and RXL (ProShares Ultra Health Care) share a meaningful slice of their top holdings — about 78% by weight. XLV is cheaper at 0.08% vs 0.95% — a difference of $87 a year per $10,000 invested.
Which is cheaper, XLV or RXL?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and RXL?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.